Trial Profile
A Randomized, Open-label, Multiple Dosing, 2-way Crossover Study to Evaluate the Effect of Sitagliptin on Pharmacokinetics of Lobeglitazone in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 May 2020
Price :
$35
*
At a glance
- Drugs Lobeglitazone (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
- 30 Apr 2020 Results published in the Clinical Therapeutics
- 14 Jul 2016 New trial record